This company listing is no longer active
ResApp Health Past Earnings Performance
Past criteria checks 0/6
Key information
-0.5%
Earnings growth rate
4.9%
EPS growth rate
Healthcare Services Industry Growth | 42.6% |
Revenue growth rate | 93.9% |
Return on equity | -1,029.0% |
Net Margin | -186.2% |
Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?
Dec 31Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?
Aug 26Here's Why We're Watching ResApp Health's (ASX:RAP) Cash Burn Situation
May 08Analysts Are Optimistic We'll See A Profit From ResApp Health Limited (ASX:RAP)
Feb 25Companies Like ResApp Health (ASX:RAP) Are In A Position To Invest In Growth
Dec 23Revenue & Expenses BreakdownBeta
How ResApp Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 22 | 4 | -7 | 5 | 6 |
31 Mar 22 | 3 | -7 | 4 | 5 |
31 Dec 21 | 0 | -7 | 4 | 5 |
30 Sep 21 | 0 | -7 | 4 | 5 |
30 Jun 21 | 1 | -7 | 4 | 4 |
31 Mar 21 | 1 | -7 | 4 | 5 |
31 Dec 20 | 0 | -8 | 4 | 5 |
30 Sep 20 | 0 | -8 | 3 | 6 |
30 Jun 20 | 0 | -8 | 3 | 7 |
31 Mar 20 | 0 | -7 | 3 | 6 |
31 Dec 19 | 0 | -6 | 2 | 6 |
30 Sep 19 | 0 | -6 | 2 | 6 |
30 Jun 19 | 0 | -5 | 2 | 6 |
31 Mar 19 | 0 | -6 | 1 | 7 |
31 Dec 18 | 0 | -7 | 1 | 7 |
30 Sep 18 | 0 | -7 | 1 | 6 |
30 Jun 18 | 0 | -7 | 2 | 6 |
31 Mar 18 | 0 | -6 | 3 | 5 |
31 Dec 17 | 0 | -6 | 3 | 4 |
30 Sep 17 | 0 | -8 | 6 | 4 |
30 Jun 17 | 0 | -10 | 8 | 3 |
31 Mar 17 | 0 | -10 | 7 | 3 |
31 Dec 16 | 0 | -9 | 7 | 2 |
30 Sep 16 | 0 | -6 | 5 | 1 |
30 Jun 16 | 0 | -3 | 2 | 1 |
31 Mar 16 | 0 | -3 | 2 | 1 |
31 Dec 15 | 0 | -2 | 2 | 1 |
30 Sep 15 | 0 | -1 | 1 | 0 |
Quality Earnings: RAP is currently unprofitable.
Growing Profit Margin: RAP is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RAP is unprofitable, and losses have increased over the past 5 years at a rate of 0.5% per year.
Accelerating Growth: Unable to compare RAP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RAP is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (1.4%).
Return on Equity
High ROE: RAP has a negative Return on Equity (-1028.99%), as it is currently unprofitable.